-They're already approved,
as the president said,
for other diseases.
As an example, many Americans
have read studies
and heard media reports
about this drug chloroquine,
which is an anti-malarial drug.
-Chloroquine -- now, this is
a common malaria drug.
And it's shown very encouraging
-- very, very encouraging --
early results.
-But the information
that you're referring
to specifically is anecdotal.
It was not done in a controlled
clinical trial,
so you really can't make any
definitive statement about it.
-Right now there's no drug
that looks like it's proven
so overwhelming
in early-stage clinical trials
that we can say
it's highly promising.
-We're going to be able to make
that drug available
almost immediately.
-I don't want to speculate about
a timeline at this point.
-So, this will take some time.
I think the good news coming out
of this press conference
is that they're prioritizing
looking into those drugs
and studying them so that,
hopefully, someday soon,
we can know if they're useful.
-We want to do that in
the setting of a clinical trial,
a large, pragmatic
clinical trial,
to actually gather
that information.
-They've gone through
the approval process.
It's been approved.
-It's already approved,
as the president said,
for the treatment of malaria
as well
as an arthritis condition.
-It's helpful that some of
these drugs
have been out there already
so we have a much better sense
of their safety profile,
but we don't know
how they act in people
who have COVID-19 infection.
-We may have the right drug,
but it may not be
in the appropriate dosage
form right now,
and that may do
more harm than good.
-There are promising therapies
produced by Gilead,
and that's, uh, remdesivoir.
Remdesivoir.
-Remdesivir.
-And that drug also
has been approved
or very close to approved
in that case by the FDA.
-It is currently
in clinical trials.
-Right now, the reality is
you cannot go into any hospital
and expect that you will
be treated with remdesivir
or with hydroxychloroquine
if you have COVID-19 infection.
-Remdesivir is going through
the normal process.
We need to actually know
about the safety
and the effectiveness,
and that's done through
the clinical-trial process.
-So, you have remdesivoir
and you have, uh,
chloroquine and hydro--
hydroxychloroquine.
So, those are two
that are out now,
essentially approved
for prescribed use,
and I think it's gonna
be very exciting.
I think it could be
a game-changer and maybe not.
And maybe not.
